| Hila Mitchell, MD | |
|
14300 Orchard Pkwy, Westminster, CO 80023-9206 | |
| (720) 627-3761 | |
| Not Available |
| Full Name | Hila Mitchell |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 14300 Orchard Pkwy, Westminster, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508154097 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | DR.0050102 (Colorado) | Secondary |
| 207Q00000X | Family Medicine | 50102 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boulder Community Health | Boulder, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Community Health | 6800707233 | 212 |
News Archive
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Today, the people behind some of the direct response television industry's most successful campaigns, launch a suite of service companies for savvy makers and marketers of direct-to-consumer goods and services.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.
› Verified 1 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Today, the people behind some of the direct response television industry's most successful campaigns, launch a suite of service companies for savvy makers and marketers of direct-to-consumer goods and services.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.
› Verified 1 days ago
| Entity Name | Boulder Community Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821074196 PECOS PAC ID: 6800707233 Enrollment ID: O20040123000284 |
News Archive
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Today, the people behind some of the direct response television industry's most successful campaigns, launch a suite of service companies for savvy makers and marketers of direct-to-consumer goods and services.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.
› Verified 1 days ago
| Entity Name | Dr Mark A Norden Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346226602 PECOS PAC ID: 0749204022 Enrollment ID: O20060125000833 |
News Archive
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Today, the people behind some of the direct response television industry's most successful campaigns, launch a suite of service companies for savvy makers and marketers of direct-to-consumer goods and services.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.
› Verified 1 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Today, the people behind some of the direct response television industry's most successful campaigns, launch a suite of service companies for savvy makers and marketers of direct-to-consumer goods and services.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.
› Verified 1 days ago
| Entity Name | Carepoint Hospital Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205330453 PECOS PAC ID: 4688939903 Enrollment ID: O20180607000495 |
News Archive
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Today, the people behind some of the direct response television industry's most successful campaigns, launch a suite of service companies for savvy makers and marketers of direct-to-consumer goods and services.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hila Mitchell, MD 5450 Western Ave, Boulder, CO 80301-2709 Ph: (303) 415-7610 | Hila Mitchell, MD 14300 Orchard Pkwy, Westminster, CO 80023-9206 Ph: (720) 627-3761 |
News Archive
MicroStockProfit.com announces an investment report featuring Cardium Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Today, the people behind some of the direct response television industry's most successful campaigns, launch a suite of service companies for savvy makers and marketers of direct-to-consumer goods and services.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.
› Verified 1 days ago
Makenzie Lewis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8510 Bryant St Ste 200, Westminster, CO 80031 Phone: 303-650-4460 Fax: 720-565-4130 | |
Dr. Hailey Holland, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14300 Orchard Pkwy, 1st Floor, Westminster, CO 80023 Phone: 303-430-5560 | |
Alla Shilman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 720-627-3761 Fax: 720-627-3758 | |
Dr. Amira Omayya Saad, D.O Family Medicine Medicare: Medicare Enrolled Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 303-430-5560 | |
Dr. James Yeash, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 11552 Sheridan Blvd, Westminster, CO 80020 Phone: 303-469-6000 | |
Dr. Stephen S Sommerschield, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7701 Sheridan Blvd, Westminster, CO 80003 Phone: 303-338-4545 | |
Gregory Thomas Hirons, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7625 W 92nd Ave, Westminster, CO 80021 Phone: 303-254-7463 Fax: 303-650-4118 |